Literature DB >> 34736

Meningitis from a pneumococcus moderately resistant to penicillin.

J C Gartner, R H Michaels.   

Abstract

Strains of pneumococci moderately resistant to penicillin were recovered from three patients at the Children's Hospital of Pittsburgh during 1978. One of these children had meningitis and showed signs of early relapse despite high doses of penicillin G potassium. Routine screening of pneumococci for penicillin resistance is recommended.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 34736

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  7 in total

Review 1.  World-wide development of antibiotic resistance in pneumococci.

Authors:  P C Appelbaum
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 2.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

Review 3.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

Review 4.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

5.  Serotypes and penicillin susceptibility of pneumococci isolated from blood.

Authors:  B A Lauer; L B Reller
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

6.  Carriage of penicillin resistant pneumococci.

Authors:  K P Klugman; H J Koornhof; A Wasas; K Storey; I Gilbertson
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

7.  Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.

Authors:  T Q Tan; G E Schutze; E O Mason; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.